Borro M, Negrini S, Long A, Chinthrajah S, Murdaca G
Clin Mol Allergy. 2021; 19(1):4.
PMID: 33849573
PMC: 8042967.
DOI: 10.1186/s12948-021-00143-y.
Greenspoon J, Kivnick S
Infect Dis Obstet Gynecol. 1993; 1(3):149-52.
PMID: 18475336
PMC: 2364304.
DOI: 10.1155/S106474499300033X.
Shepherd A, Downing J, Miyan J
Immunology. 2005; 116(2):145-63.
PMID: 16162264
PMC: 1817817.
DOI: 10.1111/j.1365-2567.2005.02223.x.
Fisher A, Le Couteur D
Drug Saf. 2001; 24(1):39-57.
PMID: 11219486
DOI: 10.2165/00002018-200124010-00004.
Ezeamuzie C, Philips E
Br J Pharmacol. 2000; 131(3):482-8.
PMID: 11015298
PMC: 1572337.
DOI: 10.1038/sj.bjp.0703556.
Influence of histamine receptor antagonists on the dynamics of the cutaneous hypersensitivity reaction in patients infected with schistosoma haematobium.
Snyman J, Sommers D, Gregorowski M
Eur J Clin Pharmacol. 1993; 44(5):467-71.
PMID: 8102968
DOI: 10.1007/BF00315545.
Chronic protracted diarrhea and jejunal atrophy in an infant. Cimetidine-associated stimulation of jejunal mucosal growth.
Fisher S, Boyle J, Holtzapple P
Dig Dis Sci. 1981; 26(2):181-6.
PMID: 7460719
DOI: 10.1007/BF01312239.
Hyperinfection syndrome with Strongyloides stercoralis.
Ali S, DORMER A
Postgrad Med J. 1981; 57(664):126-8.
PMID: 7267508
PMC: 2424801.
DOI: 10.1136/pgmj.57.664.126.
Adverse effects of anti-ulcer drugs.
Henry D, Langman M
Drugs. 1981; 21(6):444-59.
PMID: 7249945
DOI: 10.2165/00003495-198121060-00004.
Cimetidine does not accelerate skin graft rejection in mice.
Festen H, Berden J, Koene R
Clin Exp Immunol. 1980; 40(1):193-6.
PMID: 6993076
PMC: 1536940.
Immunological studies in patients with alopecia receiving dinitrochlorobenzene and cimetidine therapy.
Thestrup-Pedersen K, Bisballe S, Jensen J, Zachariae H
Arch Dermatol Res. 1982; 273(3-4):261-6.
PMID: 6984638
DOI: 10.1007/BF00409254.
Peripheral blood T lymphocytes in patients with duodenal ulcers treated with cimetidine.
Gigi M, Akriviadis E, Agorastos I, GOULIS G
Clin Exp Immunol. 1982; 48(1):186-8.
PMID: 6979447
PMC: 1536571.
The effect of cimetidine on antibody synthesis in vitro and in vivo.
Badger A, Brown A, Poste G
Immunology. 1983; 48(1):151-5.
PMID: 6848450
PMC: 1454014.
Immunostimulation. Clinical and experimental perspectives.
Drews J
Klin Wochenschr. 1984; 62(6):254-64.
PMID: 6716911
DOI: 10.1007/BF01721886.
The role of complement in the induction and regulation of immune responses.
Egwang T, Befus A
Immunology. 1984; 51(2):207-24.
PMID: 6363279
PMC: 1454432.
Coordinated therapeutic effects of immune modulators and interferon.
Cerutti I, CHANY C
Infect Immun. 1983; 42(2):728-32.
PMID: 6315585
PMC: 264490.
DOI: 10.1128/iai.42.2.728-732.1983.
Effects of the H2-receptor agonist dimaprit on lymphocyte responsiveness in vitro.
Binderup L
Agents Actions. 1984; 15(3-4):119-24.
PMID: 6240928
DOI: 10.1007/BF01972336.
The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections.
Drews J
Infection. 1984; 12(2):157-66.
PMID: 6203843
DOI: 10.1007/BF01641705.
Cimetidine prevents the induction of unresponsiveness by feeding T-dependent antigens.
Pinto M, Herzberg H
Experientia. 1981; 37(5):511-2.
PMID: 6166496
DOI: 10.1007/BF01986168.
Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.
Brogden R, Carmine A, Heel R, Speight T, Avery G
Drugs. 1982; 24(4):267-303.
PMID: 6128216
DOI: 10.2165/00003495-198224040-00002.